Nature Biotechnology reviews the state of play of senolytics
Nature Biotechnology - 12-Nov-2020In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...
Amit Sharma
Group Lead at SENS Research Foundation
Dr. Amit Sharma was awarded a Master’s degree in Biomedical Sciences from Delhi University, India. He received his PhD in 2009 in Biotechnology from University of Pune for his work demonstrating microRNA regulation of cytokines involved in allergic inflammation in mice models. Dr. Sharma’s postdoctoral research at the Buck Institute, Novato, California involved investigating novel molecular regulatory pathways in regards to genotoxic stress and cellular senescence in invertebrate and mammalian models.
Dr. Sharma has recently joined SENS Research Foundation as Group Lead in the Senescence Immunology Research Group (“ImmunoSENS”). His research focus involves studying how aging and senescence affects the immune system and his research group will also investigate strategies to harness the immune system in mitigating deleterious effects of senescent cells with translational focus.
Visit website: https://www.sens.org/about-us/staff/
See also: 
SENS Research Foundation
- Non-profit organization focused on transforming the way the world researches and treats age-related diseases
Details last updated 11-Mar-2020
Amit Sharma is also referenced in the following:
Ending Aging Forum 2022
02-Sep-2022 to 03-Sep-2022
Science and Education virtual conference organized by SENS Research Foundation (FREE)
Ending Aging Forum 2023
21-Sep-2023 to 22-Sep-2023
Virtual conference about new rejuvenation biotechnologies organized by SENS Research Foundation (Mountain View, CA, FREE)
Amit Sharma News
